TYCHE INDUSTRIES | CONCORD BIOTECH | TYCHE INDUSTRIES/ CONCORD BIOTECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 14.8 | 63.3 | 23.4% | View Chart |
P/BV | x | 1.5 | 13.6 | 11.2% | View Chart |
Dividend Yield | % | 1.3 | 0.4 | 300.2% |
TYCHE INDUSTRIES CONCORD BIOTECH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
TYCHE INDUSTRIES Mar-24 |
CONCORD BIOTECH Mar-24 |
TYCHE INDUSTRIES/ CONCORD BIOTECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 219 | 1,608 | 13.6% | |
Low | Rs | 137 | 900 | 15.3% | |
Sales per share (Unadj.) | Rs | 67.8 | 97.2 | 69.8% | |
Earnings per share (Unadj.) | Rs | 11.9 | 29.4 | 40.6% | |
Cash flow per share (Unadj.) | Rs | 13.8 | 34.6 | 40.0% | |
Dividends per share (Unadj.) | Rs | 2.50 | 8.75 | 28.6% | |
Avg Dividend yield | % | 1.4 | 0.7 | 201.1% | |
Book value per share (Unadj.) | Rs | 123.6 | 145.9 | 84.7% | |
Shares outstanding (eoy) | m | 10.25 | 104.62 | 9.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 2.6 | 12.9 | 20.4% | |
Avg P/E ratio | x | 14.9 | 42.6 | 35.0% | |
P/CF ratio (eoy) | x | 12.9 | 36.3 | 35.5% | |
Price / Book Value ratio | x | 1.4 | 8.6 | 16.8% | |
Dividend payout | % | 20.9 | 29.7 | 70.4% | |
Avg Mkt Cap | Rs m | 1,825 | 131,199 | 1.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 78 | 1,230 | 6.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 695 | 10,169 | 6.8% | |
Other income | Rs m | 59 | 338 | 17.5% | |
Total revenues | Rs m | 754 | 10,507 | 7.2% | |
Gross profit | Rs m | 126 | 4,356 | 2.9% | |
Depreciation | Rs m | 19 | 536 | 3.6% | |
Interest | Rs m | 0 | 32 | 0.1% | |
Profit before tax | Rs m | 166 | 4,126 | 4.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 44 | 1,045 | 4.2% | |
Profit after tax | Rs m | 122 | 3,081 | 4.0% | |
Gross profit margin | % | 18.2 | 42.8 | 42.5% | |
Effective tax rate | % | 26.4 | 25.3 | 104.2% | |
Net profit margin | % | 17.6 | 30.3 | 58.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 1,167 | 8,962 | 13.0% | |
Current liabilities | Rs m | 103 | 1,422 | 7.2% | |
Net working cap to sales | % | 153.0 | 74.2 | 206.4% | |
Current ratio | x | 11.3 | 6.3 | 180.0% | |
Inventory Days | Days | 31 | 94 | 33.3% | |
Debtors Days | Days | 1,004 | 1,255 | 80.0% | |
Net fixed assets | Rs m | 239 | 8,045 | 3.0% | |
Share capital | Rs m | 102 | 105 | 97.9% | |
"Free" reserves | Rs m | 1,165 | 15,162 | 7.7% | |
Net worth | Rs m | 1,267 | 15,266 | 8.3% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 1,405 | 17,007 | 8.3% | |
Interest coverage | x | 8,315.5 | 130.6 | 6,368.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.5 | 0.6 | 82.7% | |
Return on assets | % | 8.7 | 18.3 | 47.6% | |
Return on equity | % | 9.7 | 20.2 | 47.9% | |
Return on capital | % | 13.1 | 27.2 | 48.2% | |
Exports to sales | % | 64.6 | 45.9 | 140.6% | |
Imports to sales | % | 10.9 | 12.6 | 86.4% | |
Exports (fob) | Rs m | 449 | 4,670 | 9.6% | |
Imports (cif) | Rs m | 76 | 1,279 | 5.9% | |
Fx inflow | Rs m | 449 | 4,670 | 9.6% | |
Fx outflow | Rs m | 89 | 1,279 | 7.0% | |
Net fx | Rs m | 359 | 3,390 | 10.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 77 | 2,655 | 2.9% | |
From Investments | Rs m | 39 | -1,546 | -2.6% | |
From Financial Activity | Rs m | -20 | -992 | 2.1% | |
Net Cashflow | Rs m | 96 | 116 | 82.5% |
Indian Promoters | % | 62.0 | 44.1 | 140.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 17.9 | - | |
FIIs | % | 0.0 | 8.1 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 38.0 | 55.9 | 68.0% | |
Shareholders | 7,264 | 84,298 | 8.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare TYCHE INDUSTRIES With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | TYCHE INDUSTRIES | CONCORD BIOTECH | S&P BSE IT |
---|---|---|---|
1-Day | -3.64% | 4.74% | 0.36% |
1-Month | 3.53% | 1.25% | -0.70% |
1-Year | 5.93% | 55.84% | 25.98% |
3-Year CAGR | 2.77% | 28.29% | 6.24% |
5-Year CAGR | 18.44% | 16.12% | 22.26% |
* Compound Annual Growth Rate
Here are more details on the TYCHE INDUSTRIES share price and the CONCORD BIOTECH share price.
Moving on to shareholding structures...
The promoters of TYCHE INDUSTRIES hold a 62.0% stake in the company. In case of CONCORD BIOTECH the stake stands at 44.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of TYCHE INDUSTRIES and the shareholding pattern of CONCORD BIOTECH.
Finally, a word on dividends...
In the most recent financial year, TYCHE INDUSTRIES paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 20.9%.
CONCORD BIOTECH paid Rs 8.8, and its dividend payout ratio stood at 29.7%.
You may visit here to review the dividend history of TYCHE INDUSTRIES, and the dividend history of CONCORD BIOTECH.
For a sector overview, read our software sector report.
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.